Segesterone acetate and ethinyl estradiol
Annovera is a vaginal ring that releases segesterone acetate and ethinyl estradiol to prevent pregnancy. It's inserted vaginally and lasts for one year of use, with each ring providing 13 cycles of contraception. This prescription contraceptive works by combining progestin and estrogen hormones. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Annovera is a vaginal ring that releases segesterone acetate and ethinyl estradiol to prevent pregnancy. It's inserted vaginally and lasts for one year of use, with each ring providing 13 cycles of contraception. This prescription contraceptive works by combining progestin and estrogen hormones. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Segesterone acetate and ethinyl estradiol",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Segesterone acetate and ethinyl estradiol — ANDA 209627 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209627"
}
]
|
| identifier | ANDA209627 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"drug-safety",
"fda",
"health-care"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Segesterone acetate and ethinyl estradiol |
